Q06495 (NPT2A_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 116.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Sodium-dependent phosphate transport protein 2A Short name=Sodium-phosphate transport protein 2A Alternative name(s): Na(+)-dependent phosphate cotransporter 2A NaPi-3 Sodium/phosphate cotransporter 2A Short name=Na(+)/Pi cotransporter 2A Short name=NaPi-2a Solute carrier family 34 member 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 639 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | May be involved in actively transporting phosphate into cells via Na+ cotransport in the renal brush border membrane. Probably mediates 70-80% of the apical influx. |
| Subunit structure | Interacts via its C-terminal region with PDZK2 By similarity. Interacts with SLC9A3R1. Ref.4 |
| Subcellular location | |
| Tissue specificity | Kidney and lung. |
| Involvement in disease | Nephrolithiasis/osteoporosis, hypophosphatemic, 1 (NPHLOP1) [MIM:612286]: A disease characterized by decreased renal phosphate absorption, renal phosphate wasting, hypophosphatemia, hyperphosphaturia, hypercalciuria, nephrolithiasis and osteoporosis. Fanconi renotubular syndrome 2 (FRTS2) [MIM:613388]: A disease due to a generalized dysfunction of the proximal kidney tubule resulting in decreased solute and water reabsorption. Patients have polydipsia and polyuria with phosphaturia, glycosuria and aminoaciduria. They may develop hypophosphatemic rickets or osteomalacia, acidosis and a tendency toward dehydration. Some eventually develop renal insufficiency. |
| Sequence similarities | Belongs to the SLC34A transporter family. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q06495-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q06495-2) The sequence of this isoform differs from the canonical sequence as follows: 313-639: APTSMSRAEA...LPAHHNATRL → QNLEGREITHFDLRKKQAMEDSSVPHCP |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 639 | 639 | Sodium-dependent phosphate transport protein 2A | PRO_0000068607 | |||||||
Regions | |||||||||||
| Topological domain | 1 – 103 | 103 | Cytoplasmic Potential | ||||||||
| Transmembrane | 104 – 125 | 22 | Helical; Name=M1; Potential | ||||||||
| Topological domain | 126 – 145 | 20 | Extracellular Potential | ||||||||
| Transmembrane | 146 – 163 | 18 | Helical; Name=M2; Potential | ||||||||
| Topological domain | 164 – 165 | 2 | Cytoplasmic Potential | ||||||||
| Transmembrane | 166 – 185 | 20 | Helical; Name=M3; Potential | ||||||||
| Topological domain | 186 – 347 | 162 | Extracellular Potential | ||||||||
| Transmembrane | 348 – 370 | 23 | Helical; Name=M4; Potential | ||||||||
| Topological domain | 371 – 412 | 42 | Cytoplasmic Potential | ||||||||
| Transmembrane | 413 – 436 | 24 | Helical; Name=M5; Potential | ||||||||
| Topological domain | 437 – 466 | 30 | Extracellular Potential | ||||||||
| Transmembrane | 467 – 487 | 21 | Helical; Name=M6; Potential | ||||||||
| Topological domain | 488 – 513 | 26 | Cytoplasmic Potential | ||||||||
| Transmembrane | 514 – 534 | 21 | Helical; Name=M7; Potential | ||||||||
| Topological domain | 535 – 539 | 5 | Extracellular Potential | ||||||||
| Transmembrane | 540 – 561 | 22 | Helical; Name=M8; Potential | ||||||||
| Topological domain | 562 – 639 | 78 | Cytoplasmic Potential | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 508 | 1 | Phosphothreonine; by PKC Potential | ||||||||
| Glycosylation | 298 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 323 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 330 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 225 ↔ 522 | By similarity | |||||||||
| Disulfide bond | 306 ↔ 336 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 313 – 639 | 327 | APTSM…NATRL → QNLEGREITHFDLRKKQAME DSSVPHCP in isoform 2. | VSP_042311 | |||||||
| Natural variant | 48 | 1 | A → F in NPHLOP1; causes hypophosphatemic urolithiasis; results in lower phosphate current, decreases affinity for phosphate and decreases phosphate uptake compared to wild-type; shows a dominant-negative effect; requires 2 nucleotide substitutions. Ref.5 | VAR_024765 | |||||||
| Natural variant | 147 | 1 | V → M in NPHLOP1; causes hypophosphatemic osteoporosis; results in lower phosphate current, decreases affinity for phosphate and decreases phosphate uptake compared to wild-type; shows a dominant-negative effect. Ref.5 | VAR_024766 | |||||||
| Natural variant | 160 | 1 | V → VILVTVLV in FRTS2; loss of function in the homozygous state. | VAR_063812 | |||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Expression cloning of human and rat renal cortex Na/Pi cotransport." Magagnin S., Werner A., Markovich D., Sorribas V., Stange G., Biber J., Murer H. Proc. Natl. Acad. Sci. U.S.A. 90:5979-5983(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Kidney. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Kidney. |
| [3] | "The DNA sequence and comparative analysis of human chromosome 5." Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S. Rubin E.M.Nature 431:268-274(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "A new human NHERF1 mutation decreases renal phosphate transporter NPT2a expression by a PTH-independent mechanism." Courbebaisse M., Leroy C., Bakouh N., Salaun C., Beck L., Grandchamp B., Planelles G., Hall R.A., Friedlander G., Prie D. PLoS ONE 7:E34764-E34764(2012) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH SLC9A3R1. |
| [5] | "Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter." Prie D., Huart V., Bakouh N., Planelles G., Dellis O., Gerard B., Hulin P., Benque-Blanchet F., Silve C., Grandchamp B., Friedlander G. N. Engl. J. Med. 347:983-991(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS NPHLOP1 PHE-48 AND MET-147, CHARACTERIZATION OF VARIANTS NPHLOP1 PHE-48 AND MET-147. |
| [6] | "A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome." Magen D., Berger L., Coady M.J., Ilivitzki A., Militianu D., Tieder M., Selig S., Lapointe J.Y., Zelikovic I., Skorecki K. N. Engl. J. Med. 362:1102-1109(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT FRTS2 ILE-LEU-VAL-THR-VAL-LEU-VAL-160 INS, CHARACTERIZATION OF VARIANT FRTS2 ILE-LEU-VAL-THR-VAL-LEU-VAL-160 INS. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | L13258 mRNA. Translation: AAA36354.1. AK298299 mRNA. Translation: BAG60555.1. AC145098 Genomic DNA. No translation available. |
| IPI | IPI00031050. |
| PIR | B48189. |
| RefSeq | NP_001161051.1. NM_001167579.1. NP_003043.3. NM_003052.4. |
| UniGene | Hs.936. |
3D structure databases | |
| ProteinModelPortal | Q06495. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000321424. |
PTM databases | |
| PhosphoSite | Q06495. |
Polymorphism databases | |
| DMDM | 730113. |
Proteomic databases | |
| PaxDb | Q06495. |
| PRIDE | Q06495. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000324417; ENSP00000321424; ENSG00000131183. ENST00000512593; ENSP00000423022; ENSG00000131183. |
| GeneID | 6569. |
| KEGG | hsa:6569. |
| UCSC | uc003mgk.4. human. |
Organism-specific databases | |
| CTD | 6569. |
| GeneCards | GC05P176812. |
| HGNC | HGNC:11019. SLC34A1. |
| HPA | HPA051255. |
| MIM | 182309. gene. 612286. phenotype. 613388. phenotype. |
| neXtProt | NX_Q06495. |
| Orphanet | 244305. Dominant hypophosphatemia with nephrolithiasis or osteoporosis. 3337. Primary Fanconi syndrome. |
| PharmGKB | PA35887. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG1283. |
| HOGENOM | HOG000070039. |
| HOVERGEN | HBG079110. |
| InParanoid | Q06495. |
| KO | K14683. |
| OMA | LPKWLQT. |
| OrthoDB | EOG4FTW0B. |
| PhylomeDB | Q06495. |
Enzyme and pathway databases | |
| Reactome | REACT_15518. Transmembrane transport of small molecules. |
Gene expression databases | |
| ArrayExpress | Q06495. |
| Bgee | Q06495. |
| CleanEx | HS_SLC17A2. HS_SLC34A1. |
| Genevestigator | Q06495. |
| GermOnline | ENSG00000131183. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR003841. Na/Pi_transpt. [Graphical view] |
| Pfam | PF02690. Na_Pi_cotrans. 2 hits. [Graphical view] |
| TIGRFAMs | TIGR01013. 2a58. 1 hit. |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 6569. |
| NextBio | 25559. |
| SOURCE | Search... |
Entry information
| Entry name | NPT2A_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q06495 Secondary accession number(s): B4DPE3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
